Oxytocin Helps Sleep Apnea Patients Handle Opioid Drowsiness Better
Official title: Oxytocin Neurotransmission Overcomes Sleep Apnea-Related OIRD Hypersensitivity
Funded at Texas A&m University Health Science Ctr · NIH-11334368 · Data updated 2026-11-12
Aims to understand why sleep apnea makes opioids more dangerous by studying oxytocin’s role in protecting breathing, with the goal of safer pain relief for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University Health Science Ctr NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project start | August 1, 2024 |
| Project end | May 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $541,379 |
| NIH project number | 5R01DA060239-03 |
| Project ID | NIH-11334368 on NIH RePORTER |
Who could benefit from this research
✓Could help
People with sleep apnea who may require opioid pain relief could be eligible in future translational steps or related clinical studies.
✕Less likely to help
Individuals without sleep apnea or those not using opioids are less likely to directly benefit from this specific mechanism.
What this research studies
This project looks at how oxytocin in the brain may boost respiratory protection for people with sleep apnea who take opioids. Researchers will explore the brain’s oxytocin signals from the hypothalamus to respiratory centers and how they counter opioid-induced breathing suppression. The work combines animal models with physiological measurements to map pathways and test whether oxytocin can prevent or reverse dangerous breathing dips caused by opioids like fentanyl. If successful, the findings could guide new therapies that preserve pain relief while reducing overdose risk. The grant aligns closely with patient safety and could lead to new approaches for managing analgesia in sleep-disordered populations.
Why it matters
Potential benefit: If successful, this work could lead to safer opioid pain medications for people with sleep apnea by reducing the risk of breathing suppression.
How similar studies have gone: Previous studies have shown that oxytocin can influence respiration and that opioid receptors interact with breathing control, supporting a potential protective role.
Where this research is happening
-
Texas A&m University Health Science Ctr
College Station, United States Active
Researchers
- Principal investigator: Toney, Glenn M — Texas A&m University Health Science Ctr
- Study coordinator: Toney, Glenn M
Related research
Other NIH-funded projects on the same topics.
-
Improving WTC responder mental health with personalized sleep treatment for COMISA
Aimed at helping World Trade Center responders who have both insomnia and sleep apnea feel better by using a tailored combination of sleep therapies.
-
Central sleep apnea: how combined therapies could help you breathe better
This NIH grant explores how a combination of therapies, including a breathing device and a drug, might reduce central sleep apnea for people with heart failure or opioid use, by targeting the body’s breathing control system.
-
Mechanisms of sex-specific responses to sleep apnea therapies
A research project at NYU School of Medicine is exploring how men and women may respond differently to treatments for obstructive sleep apnea and related heart risk.
-
Deep learning to predict obstruction site and guide sleep apnea treatment
A patient-focused project uses snoring sounds and AI to predict where your airway collapses during sleep and to guide personalized treatments.
-
Personalized DISE-guided surgery for sleep apnea in children with Down syndrome
A personalized surgical approach guided by DISE sleep-endoscopy is being tested to better treat sleep apnea in children with Down syndrome who don’t always improve after standard surgery.
-
Biomarkers to understand obstructive sleep apnea using microRNAs
A study at the University of Pennsylvania will look for microRNA signs in the blood that reflect how bad sleep apnea is and how well CPAP therapy works for patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.